(Q37372629)

20 August 2017

1 reference

title

Dopamine vs noradrenaline: inverted-U effects and ADHD theories (English)

1 reference

attention deficit hyperactivity disorder

20 August 2017

0 references

1 reference

0 references

author name string

Florence Levy

series ordinal

1

1 reference

20 August 2017

1 February 2009

1 reference

Australian and New Zealand Journal of Psychiatry

20 August 2017

1 reference

20 August 2017

43

1 reference

20 August 2017

2

1 reference

20 August 2017

101-108

1 reference

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

20 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

The dopamine theory of attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Amphetamine: Differentiation by d and l Isomers of Behavior Involving Brain Norepinephrine or Dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Methylphenidate in Hyperkinetic Children: Differences in Dose Effects on Learning and Social Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Psychostimulant effects on academic and behavioral measures for ADHD junior high school students in a lecture format classroom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Do high doses of stimulants impair flexible thinking in attention-deficit hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Methylphenidate and cognitive perseveration in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Cellular basis of working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Stimulants: Therapeutic actions in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Neuroplasticity of neocortical circuits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Pathophysiologically based treatment interventions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Dopamine modulation of neuronal function in the monkey prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

The principal features and mechanisms of dopamine modulation in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Toward a pathophysiology of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Catecholamine modulation of prefrontal cortical cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Time reproduction, working memory, and behavioral inhibition in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670802607238

10.1080/00048670802607238

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19153917